MAHSC Inaugural Lecture Series 2026: Dr Konstantina Karabatsou

Join us in a lecture series that celebrate MAHSC Honorary Clinical Chairs in Greater Manchester, hear their professional and personal journey, clinical and research areas, plans for the future with an opportunity to share your questions.

The MAHSC Honorary Clinical Chairs are awarded on an annual basis by The University of Manchester’s Faculty of Biology, Medicine and Health Promotions Committee. They are awarded to individuals from across Greater Manchester who have made a major contribution to their clinical specialty, including excellence in research and education. There are now 86 MAHSC Honorary Clinical Chairs.

This session will be delivered by Dr Konstantina Karabatsou. Dr Karabatsou has been a Consultant Neurosurgeon at Salford Royal Hospital since 2007 having graduated from Athens, Greece, and trained in UK and Canada. She has been the lead clinician for the neuro-oncology service in Greater Manchester since 2009 and led the team in being awarded the prestigious status of designated Centre of Excellence by the Tessa Jowell Brain Cancer Mission. She is also the lead clinician for cranial neurofibromatosis type 1, as part of one of the two UK centrally commissioned multidisciplinary services.

She has held roles in the Society of British Neurosurgeons as well at the European Society and the World Federation of Neurological surgeons giving her the opportunity to contribute to educational activities and help design and promote policies and guidelines to improve neurosurgery and neuro-oncology across the world. She has been appointed as Joint Clinical Lead for Northwest Neurosurgery Specialized Services Clinical Network.

Her other passion is training and education and is the training specialty lead in meurosurgery as well as a clinical tutor for Locally Employed Doctors at NCA. She is research active, leading on clinical projects and contributing to translational and basic science projects as well as PI and co-PI of neuro-oncology related trials. Her publication record includes more than 50 peer-reviewed studies and she has been an invited speaker at several national and international courses and conferences.

Dr Karabatsou firmly believes that patients and their families must be the focus of service and brain tumour research and has also organized several well-attended patients support and information days.

We look forward to your participation and engaging discussions.